City
Epaper

'France's Covid-19 indicators improving, but vigilance needed'

By IANS | Updated: November 20, 2020 05:30 IST

Paris, Nov 20 France's Covid-19 indicators are gradually improving but the country must remain "extremely vigilant" and continue ...

Open in App

Paris, Nov 20 France's Covid-19 indicators are gradually improving but the country must remain "extremely vigilant" and continue its efforts to combat the pandemic, Health Minister Olivier Veran said.

"The virus has been circulating less quickly since the curfew and confinement were put in place. It's good news, but the pressure remains high in our hospitals. It has started to decrease gradually but it will take time. So, we must be extremely vigilant," he told a weekly briefing on the Covid-19 crisis.

On October 30, France entered a second countrywide lockdown, initially for one month, to contain a grave coronavirus resurgence, Xinhua reported.

"We are still under significant epidemic pressure... The more we apply confinement, the shorter it will last," he said. "Confinement is not over. It is not the time to talk about de-confinement. We must continue our efforts for as long as it takes to stem the virus and defeat it."

As of Thursday, 2,086,288 Covid-19 cases had been confirmed in France since the outbreak of the epidemic. In the past 24 hours, 429 people died of the respiratory disease, bringing the death toll to 47,127, official data showed.

The coronavirus-related hospital admissions dropped by 497 to 32,345, registering a decline for the third consecutive day. In addition, 4,653 Covid-19 patients required life support, down by 122 compared with Wednesday.

However, the total number of patients in intensive care all causes combined stood at 8,000, higher than the country's initial capacity of 5,100 beds, data showed.

As the world is struggling to contain the pandemic, countries including France, Germany, China, Russia, the United Kingdom and the United States are racing to find a vaccine.

According to the website of the World Health Organization, as of November 12, 212 Covid-19 candidate vaccines were being developed worldwide, 48 of them in clinical trials.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalEarthquake of magnitude 6.0 rocks Japan

CricketSixes, heartbreaks and trophies: Rohit Sharma's ODI captaincy legacy, in numbers

InternationalUS-Pakistan proximity unlikely to dent Pakistan-China ties: Expert

Other SportsSr Men Inter-Department Hockey: Police, Services, CAG, CISF, FCI win on Day 5

HealthResearch finds fat may secretly fuel Alzheimer's

Health Realted Stories

HealthBill Gates’ endorsement means India’s innovations hold great promise for Global South

HealthStudy shows size, severity of chikungunya outbreaks unpredictable

HealthHealth industry bodies welcome CGHS’ move to revise rates after 15 years

HealthRajasthan cough syrup deaths: All 19 medicines of pharma firm suspended, 3 officials removed

HealthMultidisciplinary team probing to assess cause of cough syrup deaths in MP, Rajasthan: Govt